Literature DB >> 12745086

Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells.

Takahiro Tabata1, Shinichiro Mine, Chie Kawahara, Yosuke Okada, Yoshiya Tanaka.   

Abstract

Accumulation of monocytes and the entrapment of oxidized-low-density lipoprotein (ox-LDL) in monocytes are important in the differentiation into "foam" macrophages and the pathogenesis of atherosclerosis. We investigated the role of monocyte chemoattractant protein-1 (MCP-1) in the expression of scavenger receptor (SCR) by using resting monocytes prepared by counterflow centrifugal elutriation. Our results showed that: (1) MCP-1 increased the expression of CD36 SCR by flow cytometric analysis. (2) MCP-1 increased incorporation of 125I-labeled ox-LDL and oil red O staining. (3) MCP-1 and ox-LDL enhanced in vitro transendothelial monocyte migration. (4) These functions were mediated at least in part via extracellular signal-regulated kinase (ERK) pathway. (5) MCP-1 and ox-LDL did not induce monocyte proliferation. Our results imply that MCP-1 is involved in the inflammatory process of atherosclerosis through the induction of SCR expression via the ERK pathway and differentiation of monocytes into foam macrophages, as well as induction of monocyte migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745086     DOI: 10.1016/s0006-291x(03)00771-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes.

Authors:  T Spoettl; M Hausmann; M Herlyn; M Gunckel; A Dirmeier; W Falk; H Herfarth; J Schoelmerich; G Rogler
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.

Authors:  Li Meng; Jehyun Park; Qiangjun Cai; Linda Lanting; Marpadga A Reddy; Rama Natarajan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 3.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

4.  CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Authors:  Eunhee Kim; Aaron T Tolhurst; Lu Ye Qin; Xin-Yuan Chen; Maria Febbraio; Sunghee Cho
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

Review 5.  Inflammation at the molecular interface of atherogenesis: an anthropological journey.

Authors:  Brian D Lamon; David P Hajjar
Journal:  Am J Pathol       Date:  2008-11       Impact factor: 4.307

6.  Literature mining for the discovery of hidden connections between drugs, genes and diseases.

Authors:  Raoul Frijters; Marianne van Vugt; Ruben Smeets; René van Schaik; Jacob de Vlieg; Wynand Alkema
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

Review 7.  Chemokines and cardiac fibrosis.

Authors:  Marcin Dobaczewski; Nikolaos Georgios Frangogiannis
Journal:  Front Biosci (Schol Ed)       Date:  2009-06-01

8.  Beneficial effect of Lisosan G on cultured human microvascular endothelial cells exposed to oxidised low density lipoprotein.

Authors:  Valter Lubrano; Simona Baldi; Debora Napoli; Vincenzo Longo
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

9.  Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.

Authors:  Judit Marsillach; Jordi Camps; Natàlia Ferré; Raul Beltran; Anna Rull; Bharti Mackness; Michael Mackness; Jorge Joven
Journal:  BMC Gastroenterol       Date:  2009-01-14       Impact factor: 3.067

Review 10.  Verruciform xanthoma: A view on the concepts of its etiopathogenesis.

Authors:  Usha Hegde; Vidya G Doddawad; Hs Sreeshyla; Rekha Patil
Journal:  J Oral Maxillofac Pathol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.